| 27.81 0.66 (2.43%) | 10-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 33.47 |
1-year : | 39.09 |
| Resists | First : | 28.65 |
Second : | 33.47 |
| Pivot price | 27.52 |
|||
| Supports | First : | 27.3 |
Second : | 26.46 |
| MAs | MA(5) : | 27.56  |
MA(20) : | 27.62 |
| MA(100) : | 25.88 |
MA(250) : | 25.99 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 54.3 |
D(3) : | 53.8 |
| RSI | RSI(14): 52.4 |
|||
| 52-week | High : | 32.4 | Low : | 21.47 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PHG ] has closed below upper band by 35.5%. Bollinger Bands are 10.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 27.86 - 28.06 | 28.06 - 28.21 |
| Low: | 27.18 - 27.39 | 27.39 - 27.55 |
| Close: | 27.54 - 27.86 | 27.86 - 28.11 |
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Wed, 15 Oct 2025
Callan Family Office LLC Boosts Holdings in Koninklijke Philips N.V. $PHG - MarketBeat
Mon, 13 Oct 2025
Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating A 21.94% Potential Upside - DirectorsTalk Interviews
Fri, 10 Oct 2025
Boomfish Wealth Group LLC Invests $441,000 in Koninklijke Philips N.V. $PHG - MarketBeat
Wed, 08 Oct 2025
Why Royal Philips (PHG) is a Top Value Stock for the Long-Term - Yahoo Finance
Mon, 06 Oct 2025
Here's Why Royal Philips (PHG) is a Strong Momentum Stock - Yahoo Finance
Sun, 28 Sep 2025
Ballentine Partners LLC Purchases 11,515 Shares of Koninklijke Philips N.V. $PHG - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 951 (M) |
| Shares Float | 767 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 5.3 (%) |
| Shares Short | 2,180 (K) |
| Shares Short P.Month | 2,470 (K) |
| EPS | 0.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.92 |
| Profit Margin | 0.9 % |
| Operating Margin | 9.2 % |
| Return on Assets (ttm) | 2.3 % |
| Return on Equity (ttm) | 1.5 % |
| Qtrly Rev. Growth | -2.8 % |
| Gross Profit (p.s.) | 8.23 |
| Sales Per Share | 18.78 |
| EBITDA (p.s.) | 1.7 |
| Qtrly Earnings Growth | -47 % |
| Operating Cash Flow | 1,100 (M) |
| Levered Free Cash Flow | 386 (M) |
| PE Ratio | 146.36 |
| PEG Ratio | 0 |
| Price to Book value | 2.54 |
| Price to Sales | 1.48 |
| Price to Cash Flow | 24.03 |
| Dividend | 0.97 |
| Forward Dividend | 0 |
| Dividend Yield | 3.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|